September 5th at 7.30 pm (London Time) / 2:30pm EST
This event has already occurred.
Watch the recording.
Dr. Lorraine Kalia, associate professor and clinician-scientist at the University of Toronto, will be talking to us about “Drug repurposing for PD therapies”.
Some of the most promising disease-modifying therapies being developed at the moment are based on drug repurposing (e.g. Exenatide and Ambroxol), making this webinar essential for anyone suffering from Parkinson’s or caring for someone suffering from Parkinson’s.
About the speaker:
Dr. Lorraine Kalia is an associate professor and a clinician-scientist at the University of Toronto in Canada. She is dedicated to Parkinson’s disease, both in her clinical practice as a movement disorders neurologist and in her research program as a neuroscientist.
She is the co-editor-in-chief of the Journal of Parkinson’s Disease and co-chair of the International Parkinson and Movement Disorder Society Scientific Issues Committee.
Her research focuses on understanding the fundamental molecular processes that lead to neurodegeneration in Parkinson’s disease and finding new therapies that can target these molecular culprits to slow down or even stop the disease.
Some of the most promising disease modifying therapies being developed at the moment are based on drug repurposing (e.g. Exenatide and Ambroxol), making this webinar essential for anyone suffering from Parkinson’s or caring for someone suffering from Parkinson’s.
Dr. Kalia recently presented at the World Parkinson’s Congress in Barcelona.
this should be informative.